← FDA GUIDANCE
FDA GUIDANCE · FINALMay 29, 2026
Statistical Approaches to Establishing Bioequivalence
What this record is not
Guidance details are published by the U.S. FDA; SPEQ surfaces them for reference and is not affiliated with or endorsed by the FDA. The authoritative text is on fda.gov.
Status
Final
Topic
Biopharmaceutics, Generic Drugs
Issue date
May 29, 2026
READ THE FULL GUIDANCE
The complete guidance document — every recommendation and its scope — is published by the FDA. SPEQ surfaces and indexes it for reference; the authoritative text lives on fda.gov.
View on fda.gov →